Answers are grounded in this paper and cite their sources.
e17574 Background: Testicular cancer is the most common malignancy in 15-35 year old men. It is also highly curable with over 95% five-year survival rates. However, forty percent of patients receiving platinum based cytotoxic combination chemotherapy will have oligospermia or azoospermia impairing the ability to father children. Sperm banking is an established option for fertility preservation. The aim of this retrospective survey is to assess the utilization of sperm cryopreservation and potential barriers in this young male population. Methods: Testicular cancer patients 18 years or older with more than 1 year post chemotherapy follow-up were eligible. A 5 item questionnaire including a mix of quantitative and qualitative questions was provided. Results: Two hundred patients enrolled in the study and completed the questionnaire. 139/200 (70%) patients chose not to bank sperm; 71(51%) were not interested, 25(18%) declined due to desire to immediately start chemotherapy, 24(17%) were not offered, 12(9%) declined due to cost and 7(5%) answered
No takes yet. Share an insight, caveat, or question.
Sardesai et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: